Some reports also associated CHK2 with mitotic spindle damage, through its action on BRCA1 [231]; these data, coupled with those linking this kinase to cytokinesis, indicate CHK2 as a possible target for treating cancer cells using drugs aimed at impairing the last phases of cell division [232]. This evidence concerns the gene CHEK2 and cancer.